GLP Weight Loss Clinic


Medically Supervised
GLP-1 Weight Loss Solutions in Miami

GLP-1 Weight Loss Injections for men and women looking to better manage their weight.

________________________________


Apply Online for Semaglutide, Tirzepatide, Liraglutide,  Glucagon Receptor Agonist Weight Reduction Therapy.


Lose weight safely with proper medical safeguards and protocols using the latest Glucagon Agonist medications.

________________________________


You may recognize weight-loss medication brands such as
Ozempic ®, Wegovy ®, Mounjaro ®, Zepbound ®, Saxendra ® and other peptides that are clinically proven to minimize food cravings, slow digestion, and reduce body fat.


These peptide therapies are part of a complete weight loss program for those who medically qualify with a BMI exceeding 27, a weight-related health condition, type 2 diabetes, obesity (BMI 30+), excessive weight gain, sleep apnea, high blood pressure, or cardiovascular disease.


Sign Up Today

Miami's Leading Medical Weight Loss Clinic


Learn More About

 Weight Management Programs

SEMAGLUTIDE

Semaglutide is a peptide-agonist medicine known as  GLP-1 Receptor Agonist.


Semaglutide mimics a natural hormone  in your body that regulates your appetite, digestion,  cravings, and glucose or blood sugar levels.


The hormone is known as Glucagon-Like Peptide-1 or GLP-1

TIRZEPATIDE

Tirzepatide is a dual peptide-agonist medicine known as Dual GIP/GLP-1 Receptor Agonist.


Tirzepatide mimics two natural hormones in your body that also regulate your appetite, digestion,  cravings, metabolism, and blood sugar levels.


These are GIP or Glucose-Dependent Insulinotropic Polypeptide and GLP-1, the Glucagon-Like Peptide-1 hormones.


GLP-3 PEPTIDES

GLP-3 is a triple peptide-agonist medicine known as Triple GIP & GLP-1 \ PYY Receptor Agonist


While still in development and awaiting FDA approval, Retatride is a triple-punch peptide treatment medication that is extremely promising and highly effective at targeting cravings, appetite, glucose levels, metabolism, and slowing digestion to help you lose weight.


These will simultaneously target Peptide YY or Peptide Tyrosine- Tyrosine (PYY 1-36 & PYY 3-36) which reduces appetite, GIP or Glucose-Dependent Insulinotropic Polypeptide, and  GLP-1, the Glucagon-Like Peptide-1 hormone.



Feel Fuller

GLP-1 drugs help with weight loss by helping you feel fuller and decreasing your appetite.


They work by increasing insulin and suppressing glucagon slowing digestion so you feel fuller, longer.

Reduce Cravings

By increasing the the levels of GLP-1 in your system, you can decrease your cravings for more food, especially unhealthy junk food.


GLP-1 Agonists work by reducing appetite and caloric intake.

Reduce Weight

What you eat and how often you eat directly impacts your weight. By increasing your level of satiety, slowing digestion, regulating glucose levels, and controlling hunger, GLP-1 drugs can help you lose weight and keep it off.

GLP-1 weight Loss Injections

GLP-1 Drug Disclaimer: Tirzepatide, Semaglutide, Liraglutide, Dulaglutide, Orforglipron are FDA-approved prescription medications for the treatment of type 2 diabetes and may also be prescribed for weight management when deemed appropriate by a licensed healthcare provider. Like all medications, they may cause side effects such as nausea, vomiting, constipation, diarrhea, or abdominal pain. Rare but serious risks include pancreatitis, gallbladder disease, thyroid tumors, or kidney problems. These medications are not suitable for everyone. Treatment decisions, including the choice of medication and dosage, will be made by your physician after a full medical evaluation.


All medications are dispensed through licensed U.S. pharmacies. Results vary, and weight loss is most effective when combined with medical supervision, lifestyle, and nutrition support. Brand name GLP-1 and GIP Agonists inlude Wegovy®, Ozempic®, Rybelsus®, Saxendra®, Zepbound®, Mounjaro®, Trulicity®, Foundayo®. Read more about GLP-1s at drugs.com


Medical weight loss retatrutide is under development by Eli Lily and could soon be available as a peptide therapy via telemedicine.

Learn more about GLP-1 Injections Therapy